These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1582440)

  • 21. Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway.
    Bjorkegren J; Packard CJ; Hamsten A; Bedford D; Caslake M; Foster L; Shepherd J; Stewart P; Karpe F
    J Lipid Res; 1996 Jan; 37(1):76-86. PubMed ID: 8820104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic binding of triglyceride-rich lipoproteins in humans.
    Florén CH
    Scand J Clin Lab Invest; 1985 Oct; 45(6):531-7. PubMed ID: 2999965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in plasma lipoproteins during lipolysis in vivo in the hypertriglyceridemic state.
    Karakas SE; Khilnani S; Divens C; Almario R; Jen KL
    Am J Clin Nutr; 1994 Feb; 59(2):378-83. PubMed ID: 8310988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postchallenge plasma lipoprotein retinoids: chylomicron remnants in endogenous hypertriglyceridemia.
    Wilson DE; Chan IF; Buchi KN; Horton SC
    Metabolism; 1985 Jun; 34(6):551-8. PubMed ID: 3999977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dietary fat and physiological determinants of plasma chylomicron remnant homoeostasis in normolipidaemic subjects: insight into atherogenic risk.
    Irawati D; Mamo JC; Slivkoff-Clark KM; Soares MJ; James AP
    Br J Nutr; 2017 Feb; 117(3):403-412. PubMed ID: 28215212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of remnants produced during the metabolism of triglyceride-rich lipoproteins of blood plasma and intestinal lymph in the rat.
    Mjos OD; Faergeman O; Hamilton RL; Havel RJ
    J Clin Invest; 1975 Sep; 56(3):603-15. PubMed ID: 169294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Slower catabolism of apo B48 than of apo B100 in triglyceride-rich lipoproteins during heparin infusions in type 5 hyperlipoproteinemic subjects.
    Nestel P; Billington T
    Metabolism; 1987 Feb; 36(2):172-5. PubMed ID: 3807788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity.
    Chan DC; Watts GF; Mori TA; Barrett PH; Redgrave TG; Beilin LJ
    Am J Clin Nutr; 2003 Feb; 77(2):300-7. PubMed ID: 12540386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism of chylomicrons in subjects with dysbetalipoproteinaemia (type III hyperlipoproteinaemia).
    Haffner SM; Kushwaha RS; Hazzard WR
    Eur J Clin Invest; 1989 Oct; 19(5):486-90. PubMed ID: 2511026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of chylomicron remnant metabolism by an hepatic hydroxymethylglutaryl coenzyme A reductase inhibitor.
    Cianflone K; Bilodeau M; Davignon J; Sniderman AD
    Metabolism; 1990 Mar; 39(3):274-80. PubMed ID: 2308517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chylomicron-chylomicron remnant clearance by liver and bone marrow in rabbits. Factors that modify tissue-specific uptake.
    Hussain MM; Mahley RW; Boyles JK; Fainaru M; Brecht WJ; Lindquist PA
    J Biol Chem; 1989 Jun; 264(16):9571-82. PubMed ID: 2722852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects.
    Packard CJ; Munro A; Lorimer AR; Gotto AM; Shepherd J
    J Clin Invest; 1984 Dec; 74(6):2178-92. PubMed ID: 6511922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The HMG-CoA reductase inhibitor atorvastatin increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigs.
    Burnett JR; Barrett PH; Vicini P; Miller DB; Telford DE; Kleinstiver SJ; Huff MW
    Arterioscler Thromb Vasc Biol; 1998 Dec; 18(12):1906-14. PubMed ID: 9848883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postprandial lipoproteins and progression of coronary atherosclerosis.
    Karpe F; Steiner G; Uffelman K; Olivecrona T; Hamsten A
    Atherosclerosis; 1994 Mar; 106(1):83-97. PubMed ID: 8018110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants.
    Grosskopf I; Baroukh N; Lee SJ; Kamari Y; Harats D; Rubin EM; Pennacchio LA; Cooper AD
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2573-9. PubMed ID: 16166565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chylomicron and very low-density lipoprotein apolipoprotein B metabolism: mechanism of the response to stanozolol in a patient with severe hypertriglyceridemia.
    Hazzard WR; Kushwaha RS; Applebaum-Bowden D; Haffner SM; Steinmetz A; Foster DM
    Metabolism; 1984 Oct; 33(10):873-81. PubMed ID: 6482732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interrelationship of triglycerides with lipoproteins and high-density lipoproteins.
    Gotto AM
    Am J Cardiol; 1990 Sep; 66(6):20A-23A. PubMed ID: 2203246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetics of chylomicron remnant clearance in normal and in hyperlipoproteinemic subjects.
    Cortner JA; Coates PM; Le NA; Cryer DR; Ragni MC; Faulkner A; Langer T
    J Lipid Res; 1987 Feb; 28(2):195-206. PubMed ID: 3572247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of a cardioselective beta-blocker on postprandial triglyceride-rich lipoproteins, low density lipoprotein particle size and glucose-insulin homeostasis in middle-aged men with modestly increased cardiovascular risk.
    Boquist S; Ruotolo G; Hellénius ML; Danell-Toverud K; Karpe F; Hamsten A
    Atherosclerosis; 1998 Apr; 137(2):391-400. PubMed ID: 9622282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.